These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19056443)

  • 21. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
    Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau.
    Fisker AB; Biering-Sørensen S; Lund N; Djana Q; Rodrigues A; Martins CL; Benn CS
    Vaccine; 2016 Aug; 34(38):4551-4557. PubMed ID: 27475473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DTP Hib combination.
    Joshi H; Joshi A
    Indian Pediatr; 2005 Oct; 42(10):1006; discussion 1006. PubMed ID: 16269833
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
    Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
    Griffiths UK; Korczak VS; Ayalew D; Yigzaw A
    Vaccine; 2009 Feb; 27(9):1426-32. PubMed ID: 19146901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
    Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hib IgG persistence following early booster dose.
    Slack MH; Thwaites RJ; Schapira D; Crowley-Luke A; Southern J; Miller E; Goldblatt D
    Arch Dis Child; 2005 Mar; 90(3):329. PubMed ID: 15723937
    [No Abstract]   [Full Text] [Related]  

  • 28. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of combination vaccines is associated with improved coverage rates.
    Marshall GS; Happe LE; Lunacsek OE; Szymanski MD; Woods CR; Zahn M; Russell A
    Pediatr Infect Dis J; 2007 Jun; 26(6):496-500. PubMed ID: 17529866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination vaccines: an exciting world.
    Dutta AK; Sehgal A
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S44-9. PubMed ID: 11411385
    [No Abstract]   [Full Text] [Related]  

  • 31. AEFI and the pentavalent vaccine: looking for a composite picture.
    Puliyel J
    Indian J Med Ethics; 2013; 10(3):142-6. PubMed ID: 23912725
    [No Abstract]   [Full Text] [Related]  

  • 32. [Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].
    van der Maas NA; David S; Kemmeren JM; Vermeer-de Bondt PE
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2732-7. PubMed ID: 18225797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine for India in the new millennium.
    Dutta AK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S1-5. PubMed ID: 11411379
    [No Abstract]   [Full Text] [Related]  

  • 34. Hexavalent vaccination and sudden death.
    Prescrire Int; 2004 Apr; 13(70):59. PubMed ID: 15148983
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated.
    Kerdpanich A; Warachit B; Kosuwon P; Gatchalian SR; Watanaveeradej V; Borkird T; Kosalaraksa P; Han HH; Hutagalung Y; Boutriau D; Dobbelaere K
    Int J Infect Dis; 2008 Jan; 12(1):88-97. PubMed ID: 17716936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of immune hemolytic anemia in children following immunization.
    Naleway AL; Belongia EA; Donahue JG; Kieke BA; Glanz JM;
    Vaccine; 2009 Dec; 27(52):7394-7. PubMed ID: 19766577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age.
    Poovorawan Y; Hutagalung Y; Chongsrisawat V; Thaemboonlers A; Lefevre I
    Vaccine; 2008 Mar; 26(12):1535-40. PubMed ID: 18289746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update immunization policies, guidelines and recommendations.
    John TJ
    Indian Pediatr; 1999 Jun; 36(6):567-8. PubMed ID: 10736584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.